Wed, 28th Sep 2016 10:41
LONDON (Alliance News) - Allergy vaccines developer Allergy Therapeutics PLC Wednesday said Finance Director Nick Wykeman bought 150,000 shares at a price of 17.75 pence per share on Tuesday.
The purchase is Wykeman's only holding after being appointed in June.
The stock was up 9.4% at 19.41p Wednesday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2016 Alliance News Limited. All Rights Reserved.
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.
(Alliance News) - Allergy Therapeutics PLC on Monday hailed positive findings from trial results for a peanut allergy vaccine.
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
Allergy Thera. (AGY)